RxDoctor Payments Data

Richard Ma, MD

Hospitalist · Burlington, MANPI 1013995398

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,368 of the $2,109 with a category attached, or 64.9%. 6 manufacturers reported payments, led by Arthrex at 58.5% of the total. Reporting peaked in 2019 at $1,233 and has fallen 68.8% since, to $384 in 2024. Among hospitalist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,109in general payments, 2019–2025

Across 25 payments — averaging $84.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$1K
  • Revance Therapeutics, Inc.$384
  • Merz North America, Inc.$155
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$149
  • Johnson & Johnson$100
  • E.r. Squibb & Sons, L.L.C.$88

What the payments were for

  • Travel & lodging$74035%
  • Food & beverage$1,36865%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,109 in reported general payments places this provider in the 95th percentile of 599 hospitalist providers in Massachusetts.

See all hospitalist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$57,836
Medicare patients
267
Services billed
493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban26$14,828
JantovenWarfarin Sodium90$895

Paid to pharmacies, not to this prescriber.

Other hospitalist in Burlington

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →